Anthropic adds Novartis CEO Vas Narasimhan to its board

April 14 (Reuters) - Anthropic ‌on Tuesday ​added ​Novartis' Chief Executive Officer Vas Narasimhan to its board of directors, making him ‌the first executive from the pharmaceutical industry ⁠to join the AI startup's governing body.

* Narasimhan joins ‌Anthropic CEO Dario Amodei, ‌PresidentDaniela Amodei, Confluent CEO Jay Kreps, Netflix chairman ReedHastings, and others on the board. * This marks ​the second new board addition after the Claudechatbot developer added Chris Liddell, a former Microsoftexecutive ⁠to its board in February. * Narasimhan has been appointed to Anthropic's ​board by theAnthropic Long-Term Benefit Trust, an independent body whosemembers have no financial ​stake in the company. * Anthropic ‌is reportedly weighing an initial publicoffering that could take place as early ⁠as this year. * In a LinkedIn post, the Novartis CEO said that "workingacross medicine, innovation, and global health ⁠has helped merealize that technology creates the most value when ​it'sdeployed responsibly." * "In healthcare AI is already accelerating some of ourhardest scientific challenges – from deepening our understandingof disease biology ‌to helping identify promising targets anddesign better medicines. But speed alone isn't ‌the goal"Narasimhan noted, adding "what matters just as much ⁠is how thesetools are ‌built, governed, and ​ultimately applied in the realworld."

(Reporting by Kunal Das in Bengaluru; Editing by Shailesh ‌Kuber)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Zambian police summon opposition leader for questioning
• A date on the calendar could shape the BOJ's endgame on interest rates
• Chinese court in Guangzhou accepts bankruptcy case of Evergrande unit